Dimericon Therapeutics

Dimericon Therapeutics is a startup based in Germany. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences.

Dimericon Therapeutics is a private biotech developing crosslinked helix dimer mimetics (Dimericons) to target difficult-to-drug intracellular protein-protein interactions, advancing a lead program toward IND-enabling preclinical studies for hematological malignancies following a Seed financing round.